In the experimental autoimmune encephalomyelitis model of multiple sclerosis, β2-AR–mediated signaling was able to reduce the T cell-mediated autoimmunity in experimental autoimmune encephalomyelitis by suppressing IL-2, IFN-gamma, and GM-CSF production [154]. This evidence concerns the gene IL2 and experimental autoimmune encephalomyelitis.